
The latest issue of UPJ is here! Explore the latest in urology—from AI scribes and device innovation to prostate cancer care, health equity, and real-world outcomes. 📖 Read what’s shaping the future of practice! tnyp.me/96rpyCPs/x

Where urology meets practice. Peer-reviewed insights on clinical trends, business, health policy & patient care. Official @AmerUrological journal.

The latest issue of UPJ is here! Explore the latest in urology—from AI scribes and device innovation to prostate cancer care, health equity, and real-world outcomes. 📖 Read what’s shaping the future of practice! tnyp.me/96rpyCPs/x

🔬 Prostate Biopsy Cost Comparison A study compares costs of TR-Bx and TP-Bx prostate biopsies to guide healthcare decisions. Here's what you need to know: 💰 Higher Costs - TP-Bx costs significantly more than TR-Bx due to instruments and personnel 👨⚕️ Similar Safety - Both procedures are safe and effective under local anesthesia 🛠️ Procedure Choice - Decision depends on patient-provider discussions and circumstances #ProstateBiopsy #HealthcareCosts #PatientCare tnyp.me/V4eBbCRY/x

💊 From High Cost to High Access? A study explores the impact of generic abiraterone on Medicare Part D spending for advanced prostate cancer. #Healthcare #Generics 💸 Cost Reductions - Medicare spending on abiraterone dropped from $1.5B to $910M 📈 Increased Access - Patient count rose with generic availability 💼 Policy Implication - Generic drugs can significantly cut costs tnyp.me/IkdWi0Zz/x

🔍What does it take to shape the future of urology? According to Urology Practice Editor of the Month Dr. Reza Ghavamian, it starts with curiosity, mentorship, and a commitment to challenging established practices through research and innovation. Read how his journey from practicing urologic oncologist to editorial leader continues to inspire the next generation of urologists. #Urology #Research #Innovation #Mentorship tnyp.me/ksW6L8Nm/x

🔍 Is RISK the Future of RCC Prognostication? A new study validates the Renal Cell Carcinoma Inflammatory Score (RISK) as a useful pre-surgery tool for RCC outcomes, filling an unmet need. 🧪 Evidence - RISK links with disease-free & overall survival ⚠️ Caution - Single-center validation raises generalizability concerns 💡 Impact - Potentially revolutionizes RCC prognostication with broader validation #RCC #PrognosticModels #Inflammation tnyp.me/mO5xCj5Z/x

🔬 Can Inflammatory Markers Predict RCC Outcomes? A new study validates the RCC Inflammatory Score (RISK) for predicting survival in nonmetastatic renal cell carcinoma. 📊 Prognostic Tool - RISK effectively predicts disease-free survival (DFS) and overall survival (OS) 🏥 Patient Care - Offers a low-cost, accessible pre-surgery stratification method 🧪 Biomarker Integration - Enhances existing prognostic models with preoperative inflammatory markers #RCC #CancerResearch #PrognosticModels tnyp.me/CEqHiuqj/x

💸 Can Insurance Mandates Improve Fertility Preservation? A mixed-methods study reveals gaps in accessing insurance-covered sperm banking under fertility mandates, affecting cancer patients' future reproductive options. 📉 Low Coverage - Only 1/3 of sperm banks accept insurance despite being medically necessary. 🏞️ State Disparity - 61% in mandate states accept coverage vs. 28% non-mandate. 🛠️ Systemic Barriers - Low reimbursement, delays, and lack of education persist. #FertilityPreservation #CancerCare #InsuranceGap tnyp.me/EBwa2Ipx/x

🤝 Can Better Communication Improve Cancer Screening? An editorial underscores how patient-provider dynamics impact PSA screening and highlights inequities in healthcare access. 🧪 Evidence - Weak patient-provider ties linked to less PSA testing ⚠️ Caution - Access barriers to shared decision-making exist 💡 Impact - Screenings should ensure respect and clear communication #ProstateCancer #HealthcareEquity #PSAScreening tnyp.me/fZuiKhPJ/x

🔍 How Patient-Provider Dynamics Influence Prostate Cancer Screening A recent analysis highlights how respect, collaboration, and comprehension in healthcare affect PSA screening rates in men. 📉 Lower Screening - Men perceiving lower respect/collaboration have reduced PSA screening odds 🤝 Relationship Matters - Collaborative patient-provider interactions can enhance screening access ⚖️ Modifiable Factor - Improving relationship quality may address screening disparities #ProstateCancer #PSAScreening #HealthcareInsights tnyp.me/RTQFO0AK/x

🔍 Trust & Treatment Choices in Overactive Bladder @RenaMalikMD discusses a study exploring the impact of trust, health literacy, and medical mistrust on OAB care decisions. 🧑⚕️ Gender Concordance - Physician gender doesn't affect patient trust significantly 📖 Health Literacy - Key influence on patient trust and engagement 🤔 Medical Mistrust - Higher among Black participants, impacting treatment choices #OAB #HealthLiteracy #PatientCare DOI: tnyp.me/AOaDAohK/x

💡 Hyperbaric Oxygen Therapy for Radiation Cystitis: A Closer Look An editorial highlights the promise of HBOT for radiation cystitis, urging a reevaluation of protocols and patient selection for optimal outcomes. 🧪 Evidence - 60% of patients see hematuria resolution after 20 sessions ⚠️ Caution - Lack of consensus on optimal treatment duration 💡 Impact - Could reduce need for hospitalizations and invasive treatments #HyperbaricTherapy #RadiationCystitis #UrologyCare tnyp.me/rZOhVlSP/x

🔬 Can Hyperbaric Oxygen Therapy Cure Radiation-Induced Hematuria? A study identifies factors linked with hematuria resolution in chronic radiation cystitis post-HBOT. 🩸 Quick Resolution - 60% resolved hematuria by 20 HBOT sessions 🏥 Fewer Admissions - Hematuria hospitalizations dropped significantly post-treatment 💡 Tailored Treatment - Early HBOT may improve long-term outcomes #RadiationTherapy #Hematuria #Urology #HBOT tnyp.me/F1HGB2J8/x

💰 Balancing Costs in Prostate Biopsy Choices! The ProBE-PC study analyzes TR-Bx vs. TP-Bx costs, guiding evidence-based healthcare decisions. 📊 Higher Costs - TP-Bx costs more than TR-Bx with increased healthcare resource use 💼 Decision-Making - Key for biopsy technique selection in modern clinical settings DOI: tnyp.me/V4eBbCRY/x

🧬 Fertility Preservation: Insurance Barriers Unlocked? In this Editor's Choice, the authors explore how insurance mandates for fertility preservation impact clinic acceptance. 📉 Limited Acceptance - Only 24.5% of clinics accept insurance for sperm banking. 💸 Price Range - Costs range from $50 to $2000 for sperm banking. 🚧 Overcoming Barriers - Clinic and insurer hurdles limit mandate effectiveness. #FertilityPreservation #CancerCare tnyp.me/EBwa2Ipx/x

The latest issue of Urology Practice® is now available! This month’s issue explores some of the most pressing challenges in urologic care, including patient access, health care costs, prostate cancer management, fertility preservation, residency training, and patient trust. From studies examining Medicaid access and Medicare spending to new insights into prostate biopsy approaches, robotic prostatectomy, perceptions of overactive bladder, and postoperative outcomes, this issue delivers practical research to inform everyday clinical decision-making. 📖 Read the latest issue today. tnyp.me/tJONAZ7E/x

🎓 When Does Urology Subspecialization Begin? A new study reveals that subspecialization in urology often starts during residency, aligning with future fellowship. Why does it matter? 🔍 Tailored Training - 58.5% of residents pursued fellowship, targeting key subspecialties 🩺 Case Alignment - Oncology, Pediatrics, and Endourology saw significant case focus 🏥 No Volume Effect - Institutional case volume didn’t impact fellowship choices #Urology #MedicalEducation #FellowshipTraining tnyp.me/b81BnFsM/x